IL196385A0 - Prevention and treatment of age and/or chronic excessive oxidative stress-induced diseases - Google Patents

Prevention and treatment of age and/or chronic excessive oxidative stress-induced diseases

Info

Publication number
IL196385A0
IL196385A0 IL196385A IL19638509A IL196385A0 IL 196385 A0 IL196385 A0 IL 196385A0 IL 196385 A IL196385 A IL 196385A IL 19638509 A IL19638509 A IL 19638509A IL 196385 A0 IL196385 A0 IL 196385A0
Authority
IL
Israel
Prior art keywords
age
prevention
treatment
oxidative stress
induced diseases
Prior art date
Application number
IL196385A
Original Assignee
Aharon Hoffman Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aharon Hoffman Dr filed Critical Aharon Hoffman Dr
Priority to IL196385A priority Critical patent/IL196385A0/en
Publication of IL196385A0 publication Critical patent/IL196385A0/en

Links

IL196385A 2009-01-08 2009-01-08 Prevention and treatment of age and/or chronic excessive oxidative stress-induced diseases IL196385A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL196385A IL196385A0 (en) 2009-01-08 2009-01-08 Prevention and treatment of age and/or chronic excessive oxidative stress-induced diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL196385A IL196385A0 (en) 2009-01-08 2009-01-08 Prevention and treatment of age and/or chronic excessive oxidative stress-induced diseases

Publications (1)

Publication Number Publication Date
IL196385A0 true IL196385A0 (en) 2009-09-22

Family

ID=42113378

Family Applications (1)

Application Number Title Priority Date Filing Date
IL196385A IL196385A0 (en) 2009-01-08 2009-01-08 Prevention and treatment of age and/or chronic excessive oxidative stress-induced diseases

Country Status (1)

Country Link
IL (1) IL196385A0 (en)

Similar Documents

Publication Publication Date Title
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
PL2583978T3 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
ZA201201434B (en) Use of metformin in cancer treatment and prevention
ZA200907209B (en) Prevention and treatment of cerebral amyloid angiopathy
GB0911580D0 (en) Use of one or more cannabinoids in the treatment of epilepsy
IL216154A0 (en) Prevention and treatment of nosema disease in bees
EP2651439A4 (en) Compositions and methods for the treatment or prevention of human adenovirus-36 infection
EP2206714A4 (en) Agent for prevention and/or treatment of skin diseases
HK1248535A1 (en) Treatment or prevention of infection
HK1165320A1 (en) Composition for treatment and/or prevention of dermatopathy
HK1184169A1 (en) Prevention and treatment of synucleinopathic and amyloidogenic disease
HK1171677A1 (en) Composition for the treatment of hemorrhoids and related diseases
EP2482835A4 (en) Therapy and prevention of problem drinking
EP2575824A4 (en) Methods for the treatment and prevention of inflammatory diseases
EP2454372A4 (en) Treatment and diagnosis of immune disorders
EP2491389A4 (en) Detection and treatment of lrp4-associated neurotransmission disorders
ZA201207957B (en) Prevention and treatment of gastrointestinal infection in mammals
PL2645878T3 (en) Prevention or treatment of overweight and obesity in type 2 diabetic patients
EP2470268A4 (en) Purine-targeted diagnosis and therapy of wounds
EP2436683A4 (en) Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
IL215990A0 (en) Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders
EP2244702A4 (en) Treatment of neural diseases or conditions
IL196385A0 (en) Prevention and treatment of age and/or chronic excessive oxidative stress-induced diseases
IL223219A0 (en) Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
EP2494972A4 (en) Use of gambierol for treating and/or preventing neurodegenerative diseases related to tau and beta-amyloid